Wealth Enhancement Advisory Services
KNSA icon

Wealth Enhancement Advisory Services’s Kiniksa Pharmaceuticals KNSA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio KNSA Stock Details KNSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.3M Buy
20,499
+318
+2% +$16.5K ﹤0.01% 1880
2026
Q1 		$985K Buy
20,181
+3,757
+23% +$166K ﹤0.01% 1809
2025
Q4 		$701K Buy
16,424
+771
+5% +$30.9K ﹤0.01% 2214
2025
Q3 		$597K Buy
15,653
+243
+2% +$7.89K ﹤0.01% 2221
2025
Q2 		$430K Buy
15,410
+1,846
+14% +$47K ﹤0.01% 2336
2025
Q1 		$301K Buy
+13,564
New +$279K ﹤0.01% 2451

Other funds holding KNSA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
SSC
Spruce Street Capital New York $510M AUM

Wealth Enhancement Advisory Services's KNSA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Kiniksa Pharmaceuticals (KNSA) stake by 1.6% in Q2 2026, buying an estimated $16.5K and bringing the position to 20,499 shares worth $1.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1880.

Wealth Enhancement Advisory Services first reported a position in KNSA in Q1 2025 and has held it in 6 quarters since. 266 funds tracked by Wall St. Rank hold KNSA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 20,499 shares of Kiniksa Pharmaceuticals worth $1.3M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 318 Kiniksa Pharmaceuticals shares in Q2 2026, an estimated $16.5K.
  • Kiniksa Pharmaceuticals made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #1880 holding.
  • Wealth Enhancement Advisory Services first reported a position in Kiniksa Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 266 funds tracked by Wall St. Rank held Kiniksa Pharmaceuticals as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.